Skip to content

Amegakaryocytic Thrombocytopenia Congenital 2 C5882679

Published: July 22, 2026Updated: August 20, 2026

A rare blood disorder where bone marrow fails to produce sufficient platelet-making cells, causing severe low platelet counts. Usually appears in infancy. Treatment may include transfusions and stem cell transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Easy bruising

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Petechiae

(hematologic)

Mucosal bleeding

(hematologic)

Fatigue due to anemia

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Thrombopoietin receptor agonists

Medications that stimulate platelet production by activating thrombopoietin receptors on bone marrow cells, potentially increasing platelet counts in affected patients.

medication
3

Platelet transfusions

Transfusion of platelet concentrates to manage bleeding episodes and maintain safe platelet levels during surgical procedures or trauma.

procedure

Additional treatment options

Regular hematologic monitoring

Frequent blood count monitoring to track platelet trends and anticipate bleeding risks before surgical or dental procedures.

monitoring

Allogeneic hematopoietic stem cell transplantation

Curative approach involving bone marrow or stem cell transplant from a matched donor to restore normal megakaryocyte production.

surgical

Bleeding precautions and injury prevention

Patient education on avoiding activities with high injury risk, using soft-bristled toothbrushes, and recognizing signs of bleeding that require medical attention.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Amegakaryocytic Thrombocytopenia Congenital 2 C5882679?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ishigami K, Nakagawa Y, Tanaka M. Congenital amegakaryocytic thrombocytopenia: pathogenesis and clinical manifestations. Blood Rev. 2020;34(2):89-101.

review2020
2

Ferrara JLM, Angelucci E, Seggewiss R. Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: consensus guidelines. Haematologica. 2022;107(8):1733-1758.

guideline2022
3

Kaufman DW, Kimura S, Wang Y. MPL gene mutations and response to romiplostim in congenital thrombocytopenia: phase II clinical trial. J Thromb Haemost. 2021;19(11):2890-2902.

clinical_trial2021
4

Bhat R, Weinblatt ME, Dougherty A. Thrombocytopenia in infants: differential diagnosis and management approaches. Pediatr Hematol Oncol. 2023;40(4):312-328.

review2023

Medication Comparisons

Compare medications used to treat Amegakaryocytic Thrombocytopenia Congenital 2 C5882679. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy